Biological and immunotoxicity evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on titanium

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Shi, Jue ^a   Liu, Yu ^a   Wang, Ying ^a   Zhang, Jing ^a   Zhao, Shifang ^a   Yang, Guoli ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BIOCOMPATIBLE COATED MATERIAL; TITANIUM; TOOTH IMPLANT;

ANIMAL; BIOFILM; DRUG EFFECTS; ERYTHROCYTE; HEMOLYSIS; HUMAN; IMMUNOLOGY; MALE; MICROBIAL SENSITIVITY TEST; MOUSE; PERIIMPLANTITIS; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; TENSILE STRENGTH; TOOTH IMPLANT; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; COATED MATERIALS, BIOCOMPATIBLE; DENTAL IMPLANTS; ERYTHROCYTES; HEMOLYSIS; HUMANS; MALE; MICE; MICROBIAL SENSITIVITY TESTS; PERI-IMPLANTITIS; PHOTOELECTRON SPECTROSCOPY; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES; TENSILE STRENGTH; TITANIUM;

EID: 84946782436     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16336     Document Type: Article

References (72)

1. Aglietta, M. et al. A systematic review of the survival and complication rates of implant supported fixed dental prostheses with cantilever extensions after an observation period of at least 5 years. Clin Oral Implants Res 20, 441-451 (2009).
2. Jung, R. E. et al. A systematic review of the 5-year survival and complication rates of implant-supported single crowns. Clin Oral Implants Res 19, 119-130 (2008).
3. Lang, N. P. et al. A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. II. Combined tooth-implant-supported FPDs. Clin Oral Implants Res 15, 643-653 (2004).
4. Esposito, M., Hirsch, J. M., Lekholm, U., Thomsen, P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci 106, 721-764 (1998).
5. Lang, N. P., Wilson, T. G., Corbet, E. F. Biological complications with dental implants: their prevention, diagnosis and treatment. Clin Oral Implants Res 11 Suppl 1, 146-155 (2000).
6. Chen, S., Darby, I. Dental implants: maintenance, care and treatment of peri-implant infection. Aust Dent J 48, 212-220 quiz 263 (2003).
7. Mombelli, A., Van Oosten, M. A., Schurch, E. Jr., Land, N. P. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 2, 145-151 (1987).
8. Zitzmann, N. U., Berglundh, T. Definition and prevalence of peri-implant diseases. J Clin Periodontol 35, 286-291 (2008).
9. Atieh, M. A., Alsabeeha, N. H., Faggion, C. M., Jr., Duncan, W. J. The frequency of peri-implant diseases: a systematic review and meta-analysis. J Periodontol 84, 1586-1598 (2013).
10. Francetti, L., Corbella, S., Taschieri, S., Cavalli, N., Del Fabbro, M. Medium-and Long-Term Complications in Full-Arch Rehabilitations Supported by Upright and Tilted Implants. Clin Implant Dent Relat Res (2013).
11. Frisch, E., Ziebolz, D., Ratka-Kruger, P., Rinke, S. Double Crown-Retained Maxillary Overdentures: 5-Year Follow-Up. Clin Implant Dent Relat Res (2013).
12. Frisch, E., Ziebolz, D., Rinke, S. Long-term results of implant-supported over-dentures retained by double crowns: a practicebased retrospective study after minimally 10 years follow-up. Clin Oral Implants Res 24, 1281-1287 (2013).
13. Stafford, G. L. Survival rates of short-span implant-supported cantilever fixed dental prostheses. Evid Based Dent 11, 50-51 (2010).
14. Prathapachandran, J., Suresh, N. Management of peri-implantitis. Dent Res J (Isfahan) 9, 516-521 (2012).
15. Mouhyi, J., Dohan Ehrenfest, D. M., Albrektsson, T. The peri-implantitis: implant surfaces, microstructure, and physicochemical aspects. Clin Implant Dent Relat Res 14, 170-183 (2012).
16. Heitz-Mayfield, L. J. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol 35, 292-304 (2008).
17. Venza, I. et al. Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol 81, 99-108 (2010).
18. Konstantinidis, I. K., Kotsakis, G. A., Gerdes, S., Walter, M. H. Cross-sectional study on the prevalence and risk indicators of peri-implant diseases. Eur J Oral Implantol 8, 75-88 (2015).
19. Materni, A. Managing an extreme peri-implantitis. Minerva Stomatol 62, 295-305 (2013).
20. Hultin, M. et al. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 13, 349-358 (2002).
21. Harris, L. G., Foster, S. J., Richards, R. G. An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur Cell Mater 4, 39-60 (2002).
22. Dhir, S. Biofilm and dental implant: The microbial link. J Indian Soc Periodontol 17, 5-11 (2013).
23. Renvert, S., Lindahl, C., Renvert, H., Persson, G. R. Clinical and microbiological analysis of subjects treated with Branemark or AstraTech implants: a 7-year follow-up study. Clin Oral Implants Res 19, 342-347 (2008).
24. Stewart, P. S., Costerton, J. W. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-138 (2001).
25. Zhao, L., Chu, P. K., Zhang, Y., Wu, Z. Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 91, 470-480 (2009).
26. Hancock, R. E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1, 156-164 (2001).
27. Hancock, R. E., Brown, K. L., Mookherjee, N. Host defence peptides from invertebrates-emerging antimicrobial strategies. Immunobiology 211, 315-322 (2006).
28. Hancock, R. E., Patrzykat, A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord 2, 79-83 (2002).
29. Jenssen, H., Hamill, P., Hancock, R. E. Peptide antimicrobial agents. Clin Microbiol Rev 19, 491-511 (2006).
30. Steinberg, D. A. et al. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41, 1738-1742 (1997).
31. Fjell, C. D. et al. Identification of novel antibacterial peptides by chemoinformatics and machine learning. J Med Chem 52, 2006-2015 (2009).
32. Cherkasov, A. et al. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 4, 65-74 (2009).
33. Rothan, H. A., Mohamed, Z., Suhaeb, A. M., Rahman, N. A., Yusof, R. Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide. OMICS 17, 560-567 (2013).
34. Company, N. et al. The production of recombinant cationic alpha-helical antimicrobial peptides in plant cells induces the formation of protein bodies derived from the endoplasmic reticulum. Plant Biotechnol J 12, 81-92 (2014).
35. Hilpert, K. et al. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol 16, 58-69 (2009).
36. Hale, J. D., Hancock, R. E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 5, 951-959 (2007).
37. Jenssen, H., Hancock, R. E. Therapeutic potential of HDPs as immunomodulatory agents. Methods Mol Biol 618, 329-347 (2010).
38. Song, Y. Y., Schmidt-Stein, F., Bauer, S., Schmuki, P. Amphiphilic TiO2 nanotube arrays: an actively controllable drug delivery system. J Am Chem Soc 131, 4230-4232 (2009).
39. Kazemzadeh-Narbat, M. et al. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implantassociated infections. Biomaterials 31, 9519-9526 (2010).
40. Ma, M. et al. Local delivery of antimicrobial peptides using self-organized TiO(2) nanotube arrays for peri-implant infections. J Biomed Mater Res A 100, 278-285 (2011).
41. Kazemzadeh-Narbat, M. et al. Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 34, 5969-5977 (2013).
42. Decher, G. Fuzzy nanoassemblies: Toward layered polymeric multicomposites. Science 277, 1232-1237 (1997).
43. Li, H. et al. Layer-by-layer hyaluronic acid-chitosan coating promoted new collagen ingrowth into a poly(ethylene terephthalate) artificial ligament in a rabbit medical collateral ligament (MCL) reconstruction model. J Biomater Sci Polym Ed 24, 431-446 (2013).
44. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., Gray, T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4, 2411-2423 (1995).
45. Sauerbrey, G. Physical use of a quartz vibrator for weighing thin layers on a microbalanve. Physics 155, 206-222 (1959)
46. Lau, M., Amarnath, G. S., Muddugangadhar, B. C., Swetha, M. U., Das, K. A. Tensile and shear bond strength of hard and soft denture relining materials to the conventional heat cured acrylic denture base resin: An In vitro study. J Int Oral Health 6, 55-61 (2014).
47. Drabkin, D. L. Spectrophotometric studies; the crystallographic and optical properties of the hemoglobin of man in comparison with those of other species. J Biol Chem 164, 703-723 (1946).
48. McGrath, J. C., Drummond, G. B., McLachlan, E. M., Kilkenny, C., Wainwright, C. L. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160, 1573-1576 (2010).
49. Goyarts, T., Danicke, S., Tiemann, U., Rothkotter, H. J. Effect of the Fusarium toxin deoxynivalenol (DON) on IgA, IgM and IgG concentrations and proliferation of porcine blood lymphocytes. Toxicol In Vitro 20, 858-867 (2006).
50. Tiemann, U. et al. Effects of diets with cereal grains contaminated by graded levels of two Fusarium toxins on selected immunological and histological measurements in the spleen of gilts. J Anim Sci 84, 236-245 (2006).
51. Palestrant, D. et al. Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining. Ultrastruct Pathol 28, 23-27 (2004).
52. Greenberg, N. M. et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92, 3439-3443 (1995).
53. Zhao, G. et al. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A 74, 49-58 (2005).
54. Shelma, R., Sharma, C. P. Development of lauroyl sulfated chitosan for enhancing hemocompatibility of chitosan. Colloids Surf B Biointerfaces 84, 561-570 (2011).
55. Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., Kissel, T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24, 1121-1131 (2003).
56. Roy, R. K. et al. Hemocompatibility of surface-modified, silicon-incorporated, diamond-like carbon films. Acta Biomater 5, 249-256 (2009).
57. Pandiyaraj, K. N. et al. Influence of bias voltage on diamond like carbon (DLC) film deposited on polyethylene terephthalate (PET) film surfaces using PECVD and its blood compatibility. Diamond and Related Materials 19, 1085-1092 (2010).
58. Khoshnoodi, J., Pedchenko, V., Hudson, B. G. Mammalian collagen IV. Microsc Res Tech 71, 357-370 (2008).
59. Monach, P. A., Arnold, L. M., Merkel, P. A. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum 62, 9-21 (2010).
60. Emadi, A., Jones, R. J., Brodsky, R. A. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6, 638-647 (2009).
61. Mebius, R. E., Kraal, G. Structure and function of the spleen. Nat Rev Immunol 5, 606-616 (2005).
62. Tupin, E. et al. Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation. Gene Ther 10, 569-579 (2003).
63. Son, H. Y. et al. Toxic effects of mercuric sulfide on immune organs in mice. Immunopharmacol Immunotoxicol 32, 277-283 (2010).
64. De Visser, K. E., Eichten, A., Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6, 24-37 (2006).
65. Zhu, Y. et al. Effects of aluminum exposure on the allergic responses and humoral immune function in rats. Biometals 24, 973-977 (2011).
66. Mallery, D. L. et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA 107, 19985-19990 (2010).
67. Fagarasan, S., Honjo, T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3, 63-72 (2003).
68. Holmgren, J., Czerkinsky, C. Mucosal immunity and vaccines. Nat Med 11, S45-53 (2005).
69. Racine, R. et al. IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J Immunol 186, 1011-1021 (2011).
70. Wellek, B., Hahn, H., Opferkuch, W. Opsonizing activities of IgG, IgM antibodies and the C3b inactivator-cleaved third component of complement in macrophage phagocytosis. Agents Actions 6, 260-262 (1976).
71. Lee, S. et al. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice. Int J Nanomedicine 8, 147-158 (2013).
72. Steinberg, D., Klinger, A., Kohavi, D., Sela, M. N. Adsorption of human salivary proteins to titanium powder. I. Adsorption of human salivary albumin. Biomaterials 16, 1339-1343 (1995).